Open label study to investigate patch adhesion of an Esflurbiprofen-containing patch in healthy volunteers

Phase 1

• Conditions: patch adhesion trial with healthy subjects, therapeutical indication not studied; MedDRA version: 20.0Level: LLTClassification code: 10028338Term: Muscle sprains Class: 10022117; MedDRA version: 20.0Level: LLTClassification code: 10002550Term: Ankle sprains and strains Class: 10022117; MedDRA version: 20.0Level: LLTClassification code: 10028361Term: Muscular pain Class: 10028395; MedDRA version: 20.1Level: LLTClassification code: 10006502Term: Bruise Class: 10022117; MedDRA version: 21.1Level: LLTClassification code: 10028362Term: Muscular pains Class: 10028395; MedDRA version: 20.0Level: LLTClassification code: 10002549Term: Ankle sprain Class: 10022117; MedDRA version: 20.0Level: LLTClassification code: 10028337Term: Muscle sprain Class: 10022117; Therapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]

• Registration Number: CTIS2023-503609-12-00
• Lead Sponsor: Teikoku Seiyaku Co. Ltd.

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2023-03-23
• Study Completion: 2023-12-13
• Last Update Posted: 22 July 2024

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Main Objective: ;Secondary Objective: ;Primary end point(s):